A Glycine Carbonate (2:1), Monosodium Salt CEP of the European Pharmacopoeia monograph is often referred to as a Glycine Carbonate (2:1), Monosodium Salt Certificate of Suitability (COS). The purpose of a Glycine Carbonate (2:1), Monosodium Salt CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Glycine Carbonate (2:1), Monosodium Salt EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Glycine Carbonate (2:1), Monosodium Salt to their clients by showing that a Glycine Carbonate (2:1), Monosodium Salt CEP has been issued for it. The manufacturer submits a Glycine Carbonate (2:1), Monosodium Salt CEP (COS) as part of the market authorization procedure, and it takes on the role of a Glycine Carbonate (2:1), Monosodium Salt CEP holder for the record. Additionally, the data presented in the Glycine Carbonate (2:1), Monosodium Salt CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Glycine Carbonate (2:1), Monosodium Salt DMF.
A Glycine Carbonate (2:1), Monosodium Salt CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Glycine Carbonate (2:1), Monosodium Salt CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Glycine Carbonate (2:1), Monosodium Salt suppliers with CEP (COS) on PharmaCompass.